MANILA, Philippines — The World Health Organization (WHO) will no longer include an anti-cancer drug in its solidarity trials in the Philippines for possible COVID-19 treatment, the Department of Health (DOH) said Monday.
“‘Yung Acalabrutinib, hindi, hindi siya matutuloy, nagbigay na ng recommendation ang WHO. It’s not going to be part of the solidarity trials anymore,” Health Undersecretary Maria Rosario Vergeire said in a virtual media forum.
(Acalabrutinib will no longer be included. The WHO has already made its recommendation. It will not be part of the solidarity trials anymore.)
Vergeire said acalabrutinib has not yet been administered to anyone here in the country for t…
Keep on reading: Anti-cancer drug excluded from WHO solidarity trials in PH – DOH